Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluoride SCHEMBL28444337 | 0.98 | MEN1 (0.32) | MEN1HSP90AA1KMT2ASMN1; SMN2 | |
| SCHEMBL15720671 | 0.98 | MEN1 (0.32) | MEN1HSP90AA1KMT2ASMN1; SMN2 | |
| Fluoride Ion SCHEMBL1898576 | 0.95 | MEN1 (0.31) | MEN1HSP90AA1KMT2ASMN1; SMN2 | |
| Iodide SCHEMBL180141 | 0.95 | MAOA (0.32) | MEN1HSP90AA1KMT2ASMN1; SMN2 | |
| Water SCHEMBL28929077 | 0.95 | MEN1 (0.31) | MEN1HSP90AA1KMT2ASMN1; SMN2 | |
| Bromide SCHEMBL557294 | 0.95 | MEN1 (0.34) | MEN1HSP90AA1KMT2ASMN1; SMN2 | |
| Iodide SCHEMBL3774569 | 0.95 | MEN1 (0.31) | MEN1HSP90AA1KMT2ASMN1; SMN2 | |
| SCHEMBL25362450 | 0.90 | — | — | |
| SCHEMBL15732334 | 0.90 | — | — | |
| SCHEMBL1681982 | 0.90 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 326 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250188048-A1 | METHOD FOR PREPARING 2,5-FURANDICARBOXYLIC ACID COMPOUND | JIANGSU CELLURANICS NEW MATERIAL TECHNOLOGY CO., LTD. (CN) | 2025-06-12 | — | — | US | claimed |
| US-12240922-B1 | Transition metal complex assisted green hydrolysis for nanocellulose extraction | UNITED ARAB EMIRATES UNIVERSITY (AE) | 2025-03-04 | — | — | US | claimed |
| EP-4477651-A1 | METHOD FOR PREPARING 2,5-FURANDICARBOXYLIC ACID COMPOUND | Jiangsu Celluranics New Material Technology Co., Ltd. (CN) | 2024-12-18 | — | — | EP | claimed |
| CN-119049824-A | Magnetorheological shear thickening fluid with flame retardant and anti-sedimentation effects and preparation method thereof | 中国科学技术大学 | 2024-11-29 | — | — | CN | claimed |
| CN-113773403-B | Preparation method of cellulose oligosaccharide and cellooligosaccharide graft polymer prepared by preparation method | 安徽农业大学 | 2022-11-25 | — | — | CN | claimed |
| CN-112624131-B | Preparation method of monodisperse large-particle-size silicon dioxide microspheres | 深圳先进电子材料国际创新研究院 | 2022-09-06 | — | — | CN | claimed |
| CN-112791010-B | Chestnut shell aerogel and preparation method and application thereof | 华南理工大学 | 2022-05-24 | — | — | CN | claimed |
| CN-114420896-A | High-rate lithium battery negative electrode piece and preparation method and application thereof | 中国科学院上海硅酸盐研究所 | 2022-04-29 | — | — | CN | claimed |
| CN-109651114-B | Method for synthesizing alkyl aromatic aldehyde | 中国石油化工股份有限公司 | 2022-04-05 | — | — | CN | claimed |
| CN-109647528-B | Catalyst for synthesizing alkyl aromatic aldehyde | 中国石油化工股份有限公司 | 2022-04-05 | — | — | CN | claimed |
| WO-2009102305-A1 | TREATMENT OF CELLULOSE ESTERS | EASTMAN CHEMICAL COMPANY (US) | 2009-08-20 | — | — | WO | claimed |
| WO-2009102419-A2 | ALUMINUM RECOVERY PROCESS | THE UNIVERSITY OF ALABAMA (US) | 2009-08-20 | — | — | WO | claimed |
| US-20090203899-A1 | TREATMENT OF CELLULOSE ESTERS | EASTMAN CHEMICAL COMPANY (US) | 2009-08-13 | — | — | US | claimed |
| US-7347920-B2 | Production, refining and recycling of lightweight and reactive metals in ionic liquids | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2008-03-25 | — | — | US | claimed |
| EP-1311472-B1 | METHOD FOR PREPARING ALKOXYAMINES FROM NITROXIDES | ATOFINA (FR) | 2004-10-20 | — | — | EP | claimed |
| US-6700007-B2 | IN A BIPHASIC MEDIUM, BY MIXING AN IONIC LIQUID SUCH AS AN ALKYLIMIDAZOLIUM HALIDE, AN ORGANIC SOLVENT, A TRANSITION METAL SALT, A METAL LIGAND, A HALOHYDROCARBON AND A NITROXIDE | ATOFINA (FR) | 2004-03-02 | — | — | US | claimed |
| US-6579343-B2 | Contacting gas with a liquid ionic compound comprising a nitrogen-containing heterocyclic cation | UNIVERSITY OF NOTRE DAME DU LAC | 2003-06-17 | — | — | US | claimed |
| US-20030050507-A1 | Method for prepararing alkoxyamines from nitroxides | ATOFINA (FR) | 2003-03-13 | — | — | US | claimed |
| US-20020189444-A1 | Purification of gas with liquid ionic compounds | NATIONAL SCIENCE FOUNDATION | 2002-12-19 | — | — | US | claimed |
| EP-0693045-B1 | ALKYLATION PROCESS | BP CHEM INT LTD (GB) | 1997-10-22 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030050507-A1 | Method for prepararing alkoxyamines from nitroxides | ZYX, ZFX, PNMT | MEN1 4242/4885HSP90AA1 4154/4885KMT2A 428/4885 |
| US-20250188048-A1 | METHOD FOR PREPARING 2,5-FURANDICARBOXYLIC ACID COMPOUND | HPD, DPYD, PGD | MEN1 4667/4885HSP90AA1 3762/4885KMT2A 3074/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.